Marshall Wace’s Xponential Fitness XPOF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,251
Closed -$224K 3824
2026
Q1
$224K Sell
37,251
-862,695
-96% -$6.23M ﹤0.01% 2743
2025
Q4
$7.41M Sell
899,946
-359,065
-29% -$2.55M 0.01% 984
2025
Q3
$9.81M Buy
1,259,011
+151,506
+14% +$1.38M 0.01% 924
2025
Q2
$8.3M Buy
1,107,505
+223,688
+25% +$1.85M 0.01% 926
2025
Q1
$7.36M Buy
883,817
+243,048
+38% +$3.39M 0.01% 890
2024
Q4
$8.62M Buy
640,769
+544,382
+565% +$7.49M 0.01% 851
2024
Q3
$1.2M Sell
96,387
-790,023
-89% -$11.6M ﹤0.01% 1576
2024
Q2
$13.8M Sell
886,410
-131,611
-13% -$1.62M 0.02% 608
2024
Q1
$16.8M Sell
1,018,021
-65,594
-6% -$806K 0.03% 573
2023
Q4
$14M Sell
1,083,615
-90,513
-8% -$1.23M 0.02% 586
2023
Q3
$18.2M Buy
1,174,128
+502,436
+75% +$9.85M 0.04% 468
2023
Q2
$11.6M Sell
671,692
-343,418
-34% -$9.72M 0.02% 666
2023
Q1
$30.8M Buy
1,015,110
+636,356
+168% +$16.8M 0.07% 317
2022
Q4
$8.68M Buy
378,754
+143,217
+61% +$2.95M 0.02% 876
2022
Q3
$4.3M Buy
+235,537
New +$3.97M 0.01% 1478
2022
Q1
Sell
-32,744
Closed -$669K 4121
2021
Q4
$669K Buy
+32,744
New +$608K ﹤0.01% 2657

Other funds holding XPOF

Marshall Wace's XPOF Position: Q2 2026 in Review

Marshall Wace sold out of Xponential Fitness (XPOF) in Q2 2026, closing a stake of 37,251 shares — an estimated $224K sold.

Marshall Wace first reported a position in XPOF in Q4 2021 and held it in 16 quarters. The position peaked at $30.8M in Q1 2023. 117 funds tracked by Wall St. Rank hold XPOF as of Q2 2026.

  • Marshall Wace reported no remaining Xponential Fitness position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 37,251 Xponential Fitness shares in Q2 2026, an estimated $224K.
  • Marshall Wace first reported a position in Xponential Fitness in Q4 2021 and held it in 16 quarters.
  • Marshall Wace's Xponential Fitness position peaked at $30.8M in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Xponential Fitness as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.